HealthAlnylam Reports $2.17 Billion in Q3 Net Income, Including Tax BenefitBy Naomi CalderNov 17, 2026, 7:20 PM UTC
HealthPTC Therapeutics Raises 2026 Product Revenue Forecast After Sephience GrowthBy Naomi CalderOct 30, 2026, 3:29 AM UTC